U.K. terminates its contract with Valneva—wiping out almost half its market cap
#1

Also Bye Bye to UK's approval

The U.K. government said it had terminated the contract because Valneva was in breach of its obligations under the deal—a claim Valneva “strenuously” denies.

The laboratory noted at the end of August that based on Phase I and Phase II trials, it hoped to have a vaccine that is more than 80% effective.

Valneva warned of a “substantial risk” to exporting the vaccine between the EU and the U.K. owing to supply chain issues.

Back in April, talks between Valneva and the European Commission also broke down because, the EU executive said, the company failed to meet “a certain set of conditions.” Valneva’s prioritization of the U.K.’s order was reportedly a factor.

https://fortune.com/2021/09/13/uk-termin...arket-cap/
Reply


Forum Jump:


Users browsing this thread: 2 Guest(s)